CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...
Phase 2
Budapest, Hungary and 8 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Budapest, Hungary and 50 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Budapest, Hungary and 210 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...
Phase 2
Budapest, Hungary and 40 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Törökbálint, Hungary and 95 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Törökbálint, Hungary and 17 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Budapest, Hungary and 262 other locations
growth factor A (VEGF-A) in participants with non-small cell lung cancer (NSCLC).The study will comprise several cohorts for dose ...
Phase 1
Budapest, Hungary and 44 other locations
The primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.
Phase 1
Budapest, Hungary and 35 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Budapest, Hungary and 235 other locations
Clinical trials
Research sites
Resources
Legal